The next few months could prove pivotal for marijuana producer Canopy Growth (NASDAQ: CGC) . The company will report earnings at the start of June, and its unofficial partner Acreage Holdings (OTC: ACRGF) is testing its beverages in the U.S. to evaluate the market waters. These are among a few significant catalysts that could impact Canopy Growth's share price over the coming months and determine its path for the rest of the year.
While shares of Horizons Marijuana Life Sciences ETF are up over 20%, shares of Canopy stock are down 5% year to date and trading around this year's lowest levels. Should you consider investing in Canopy Growth over the next few months, or is it still too risky?
Image source: Getty Images.
For further details see:
Is Canopy Growth a Buy for Summer 2021?